US Stock MarketDetailed Quotes

KRRO Korro Bio

Watchlist
  • 51.300
  • +1.050+2.09%
Close May 31 16:00 ET
  • 51.300
  • 0.0000.00%
Post 16:02 ET
475.70MMarket Cap-5066P/E (TTM)

About Korro Bio Company

Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Company Profile

SymbolKRRO
Company NameKorro Bio
Listing DateOct 3, 2019
Founded2018
CEODr. Ram Aiyar, M.B.A.,PhD
MarketNASDAQ
Employees102
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressOne Kendall Square,Building 600-700,Suite 6-401
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-468-1999
Websitehttp://www.korrobio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ram Aiyar, M.B.A.,PhD
  • Director, President and Chief Executive Officer
  • --
  • Vineet Agarwal, M.B.A.
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Todd Chappell, M.B.A.
  • Chief Operating Officer
  • --
  • Dr. Steve Colletti, PhD
  • Chief Scientific Officer
  • --
  • Shelby J. Walker, J.D.,M.S.
  • Senior Vice President, General Counsel and Corporate Secretary
  • --
  • Dr. Nessan Bermingham, PhD
  • Chairman of the Board
  • --
  • Rachel Meyers
  • Director
  • --
  • David L. Lucchino
  • Director
  • --
  • Timothy R. Pearson
  • Independent Director
  • --
  • Dr. Jean-Francois Formela,M.D.
  • Independent Director
  • --
  • Dr. Ali Behbahani, M.B.A.,M.D.
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg